Commercial Credit Report for Calypte Biomedical Corporation (United States)

Preview

This is a Preview, click here for the full commercial credit report.

Calypte Biomedical Corporation
16290 S.W. Upper Boones Ferry
Phone: (503) 726-2227	Portland, OR 97224 United States	Ticker: CBMC

Business Summary

Calypte Biomedical Corporation develops, manufactures, and distributes in vitro diagnostic tests, primarily for the diagnosis of Human Immunodeficiency Virus (HIV) infection. It is focused on the development and commercialization of the Aware HIV-1/2 rapid tests. Its product line includes the Aware line of rapid tests, the Aware HIV-1 BED Incidence test and the Aware Messenger specimen collection device.

(Source: 10-K)

Financial Information

Financial Ratings:	Z'' Score FRISK Score
Latest Financial Statements and Analyses:	3/31/2010 Annual Financials Quarterly Financials
Current Fiscal Period:	1Q 2010
Fiscal Year End:	December
Last Audit:	12/31/2009
Auditors:	Odenberg Ullakko Muranishi & Co.
Audit Opinion:	Unqualified
Public Filings:	Suits & Judgments
SEC Filings:	Management Discussion & Analysis Full Filings

Industries

Type

Code

Description

Sector

TECHNO

Technology

Industry

SCIINS

Scientific & Technical Instr.

SIC

3826

Laboratory Analytical Instruments

NAICS

334516

Analytical Laboratory Instrument Manufacturing

Management

Title

Name

Age

Title Date

Start Date

Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary

Adel Karas

2/5/2010

5/8/2007

Director

Tareq Al Yousefi

9/24/2009

Director

Kartlos Edilashvili

2/4/2010

Business Names

Business Name

Beijing Calypte Biomedical Technology Ltd. People�s Republic of China

Beijing Marr Bio-Pharmaceuticals Co., Ltd. People�s Republic of China

Calypte Biomedical Corporation

General Information

Number of Employees:	3	(As of 12/31/2009)
Outstanding Shares:	477,344,052	(As of 6/18/2010)
Shareholders:	392	(As of 12/31/2009)
Stock Exchange:	OTC
Federal Tax Id:	061226727